Intco Medical Technology Co
Intco Medical Technology Co., Ltd., commonly referred to as Intco Medical, is a leading player in the medical supplies industry, headquartered in China. Established in 1993, the company has expanded its operations across various regions, including North America, Europe, and Asia, solidifying its global presence. Specialising in disposable medical products, Intco Medical is renowned for its high-quality offerings, including gloves, wound care supplies, and rehabilitation equipment. The company’s commitment to innovation and quality has earned it a strong market position, with notable achievements in product development and customer satisfaction. With a focus on enhancing healthcare standards, Intco Medical continues to set benchmarks in the industry, making it a trusted name among healthcare professionals worldwide.
DitchCarbon Score
How does Intco Medical Technology Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Intco Medical Technology Co's score of 27 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Intco Medical Technology Co's reported carbon emissions
In 2023, Intco Medical Technology Co., headquartered in CN, reported significant carbon emissions, totalling approximately 1,409,300,000 kg CO2e for Scope 1 and about 290,800,000 kg CO2e for Scope 2. This reflects a notable increase in emissions compared to 2022, where Scope 1 emissions were around 1,045,500,000 kg CO2e and Scope 2 emissions were about 178,900,000 kg CO2e. The company has not disclosed any Scope 3 emissions data. Intco Medical has committed to a long-term sustainability roadmap, aiming to peak its carbon emissions by 2029 and achieve full carbon neutrality by 2050. This commitment encompasses both Scope 1 and Scope 2 emissions, indicating a comprehensive approach to reducing its carbon footprint. The roadmap was publicly released in 2021 and outlines the company's strategy for sustainable development through to 2030. Overall, Intco Medical's emissions data and climate commitments reflect a proactive stance towards addressing climate change, with clear targets set for the coming decades.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 988,700,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 239,800,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Intco Medical Technology Co is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
